Company Description
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China.
It operates in two segments, Network and Hospital. The company’s services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.
Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners.
In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel.
Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment.
Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services.
Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.
| Country | China |
| Founded | 1997 |
| IPO Date | Dec 11, 2009 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 595 |
| CEO | Jianyu Yang |
Contact Details
Address: East Zone, Hanwei Plaza, Room A1-A5, 26th Floor Beijing, 100020 China | |
| Phone | 86 10 5903 6688 |
| Website | concordmedical.com |
Stock Details
| Ticker Symbol | CCM |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| CIK Code | 0001472072 |
| CUSIP Number | 206277105 |
| ISIN Number | US2062771058 |
| SIC Code | 8011 |
Key Executives
| Name | Position |
|---|---|
| Dr. Jianyu Yang | Chairman and Chief Executive Officer |
| Wei Jiang | Chief Financial Officer |
| Boxun Zhang | Chief Strategy Officer |
| Xun Liu | Financial Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 29, 2025 | 6-K | Report of foreign issuer |
| May 29, 2025 | 6-K | Report of foreign issuer |
| May 13, 2025 | 6-K | Report of foreign issuer |
| May 8, 2025 | 6-K | Report of foreign issuer |
| Apr 25, 2025 | 6-K | Report of foreign issuer |
| Apr 25, 2025 | 20-F | Annual and transition report of foreign private issuers |
| Apr 11, 2025 | 6-K | Report of foreign issuer |
| Jan 6, 2025 | 6-K | Report of foreign issuer |
| Dec 9, 2024 | 6-K | Report of foreign issuer |
| Nov 13, 2024 | 6-K | Report of foreign issuer |